Literature DB >> 26183850

MiR-142-3p Suppresses SOCS6 Expression and Promotes Cell Proliferation in Nasopharyngeal Carcinoma.

Xiaoming Qi, Jianqiang Li, Changbo Zhou, Chunlei Lv, Min Tian.   

Abstract

BACKGROUND/AIMS: An increasing number of studies show that microRNAs (miRNAs) play crucial roles in nasopharyngeal carcinoma (NPC) tumorigenesis. The aim of our study was to investigate the biological roles and mechanisms of miR-142-3p in NPC.
METHODS: miR- 142-3p expression was examined in NPC specimens and nasopharyngitis biopsy samples by quantitative real-time PCR. The biological functions of miR-142-3p were studied using a series of in vitro and in vivo approaches.
RESULTS: miR-142-3p is over-expressed in NPC tissues and cell lines. Knockdown of miR-142-3p significantly inhibited cell proliferation and cell cycle progression in vitro, and suppressed tumor growth in a mouse model. Suppressor of cytokine signaling 6 (SOCS6) was identified as a direct target of miR-142-3p, and miR- 142-3p down-regulated the expression of SOCS6 by directly binding to its 3′untranslated region (UTR). Knockdown of SOCS6 abrogated the effects of miR-142-3p down-regulation.
CONCLUSION: These findings indicate that miR-142-3p regulates NPC development by down-regulating SOCS6 expression and suggest that modulation of miR-142-3p expression could be a therapeutic strategy for NPC.
Copyright © 2015 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26183850     DOI: 10.1159/000430147

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  14 in total

1.  Effects of radiotherapy on nasopharyngeal carcinoma cell invasiveness.

Authors:  Zheng Peng; Tiancai Xu; Xiaofang Liao; Huijuan He; Wansu Xu
Journal:  Tumour Biol       Date:  2015-08-29

2.  miR-24-3p stimulates migration, invasion and proliferation of prostate cancer cells by targeting suppressor of cytokine signaling 6.

Authors:  Yang Lin; Huifang Cao; Yuxin Tian; Xinping Yang; Changdong Zhou; Qifu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  A novel microRNA-based signature predicts prognosis among nasopharyngeal cancer patients.

Authors:  Tianyu Wang; Jian Wu; Yun Wu; Yin Cheng; Yue Deng; Jianchun Liao; Huanhai Liu; Hu Peng
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-17

4.  Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.

Authors:  Minglei Liu; Kangru Zhu; Xinmei Qian; Wei Li
Journal:  Med Sci Monit       Date:  2016-06-28

5.  MiR-142 inhibits the development of cervical cancer by targeting HMGB1.

Authors:  Daqiong Jiang; Huiyan Wang; Zhuyan Li; Zhen Li; Xin Chen; Hongbing Cai
Journal:  Oncotarget       Date:  2017-01-17

6.  PTENP1 inhibits the growth of esophageal squamous cell carcinoma by regulating SOCS6 expression and correlates with disease prognosis.

Authors:  Tuotuo Gong; Shuyu Zheng; Shan Huang; Shenbo Fu; Xuanwei Zhang; Shupei Pan; Tian Yang; Yuchen Sun; Ya Wang; Beina Hui; Jia Guo; Xiaozhi Zhang
Journal:  Mol Carcinog       Date:  2017-08-21       Impact factor: 4.784

7.  miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1.

Authors:  Zhihui Wang; Zhiquan Zhu; Zhong Lin; Youli Luo; Zibin Liang; Caibin Zhang; Jianxu Chen; Peijian Peng
Journal:  Cancer Cell Int       Date:  2019-04-30       Impact factor: 5.722

8.  MiR-32-5p Regulates Radiosensitization, Migration And Invasion Of Colorectal Cancer Cells By Targeting TOB1 Gene.

Authors:  Hong Liang; Yumei Tang; Hui Zhang; Chao Zhang
Journal:  Onco Targets Ther       Date:  2019-11-14       Impact factor: 4.147

9.  miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway.

Authors:  Zhang Xuefang; Zheng Ruinian; Jiang Liji; Zhang Chun; Zheng Qiaolan; Jia Jun; Chen Yuming; Huang Junrong
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  miR-142 suppresses proliferation and induces apoptosis of osteosarcoma cells by upregulating Rb.

Authors:  Yan-Fang Gao; Qiu-Jie Zhang; Zhuang Yu; Shi-Hai Liu; Jun Liang
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.